580 results on '"Wiegand, Susanne"'
Search Results
2. Association between malformation type, location and functional deficits in lymphatic malformations of the head and neck in children
3. Digitale Patient-Reported Outcome Measures in der Nachsorge von Kopf-Hals-Tumoren
4. Improved survival of locoregional-advanced larynx and hypopharynx cancer patients treated according to the DeLOS-II protocol
5. Ösophagusdivertikel
6. German S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” – Long version of the update 2023
7. Treatment per DeLOS-II protocol improves outcome of patients with locally advanced Laryngeal and Hypopharyngeal squamous cell carcinoma compared to conventional regimens
8. Die Weiterbildung „Medikamentöse Tumortherapie“ in deutschen HNO-Abteilungen – eine Umfrage der AG Onkologie der DGHNO
9. Adenocarcinoma of the supraglottis in a lung transplant patient
10. Frailty, a previously underestimated risk factor in treatment of elderly patients with HNSCC
11. Adenokarzinom der Supraglottis bei einem lungentransplantierten Patienten
12. The importance of Immunotherapy in 2013/14 vs. 2022/23 – A survey of the DGHNO Oncology Working Group
13. Der Stellenwert der Immuntherapie 2013/14 vs. 2022/23 – eine Umfrage der AG Onkologie der DGHNO
14. Development of a prediction model for the detection of recurrent and second primary cancer (RCA) using Patient Reported Outcome Measurement (PROM)
15. Entwicklung eines Modells zur Detektion von Rezidiven und Zweitkarzinomen (RCA) mittels Patient Reported Outcome Measurement (PROM)
16. Advanced training in systemic oncologic therapy in German Otorhinolaryngology departments – A survey of the DGHNO Oncology Working Group
17. Wirtschaftliche Auswirkungen von Kopf-Hals-Tumoren
18. The economic impact of head and neck cancer
19. Frailty, ein bislang unterschätzter Risikofaktor in der Therapie älterer Patienten mit HNSCC
20. Outcome differences of advanced larynx/hypopharynx cancer DeLOS-II trial patients related to human leukocyte antigens and haplotypes
21. Outcome differences of patients with early stage glottic or supraglottic cancer emphasize the importance of a precise examination and description of tumor localization
22. Erstlinien-Standards in der palliativen Systemtherapie in Deutschland- eine Umfrage der AG Onkologie der DGHNO
23. Update: Epidemiologie und Prävention des Oropharynxkarzinoms
24. Plattenepithelkarzinome des Kopf- und Halsbereichs: Bewährte und innovative Strategien verbessern Outcome
25. Endoluminale Therapie des Zenker-Divertikels aus Perspektive der HNO
26. Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind,...
27. Dysphagia, voice problems, and pain in head and neck cancer patients
28. Cancer-associated financial burden in German head and neck cancer patients
29. Outcome differences in HPV-driven head and neck squamous cell carcinoma attributable to altered human leukocyte antigen frequencies
30. S3‐Leitlinie “Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Update 2023, Teil 2: Epidemiologie und Ätiologie, Diagnostik, Therapie des invasiven Plattenepithelkarzinoms der Haut, Nachsorge und Prävention
31. S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention
32. Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome
33. S3‐Leitlinie “Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Update 2023, Teil 1: Therapie der aktinischen Keratose, Morbus Bowen, Cheilitis actinica, berufsbedingte Erkrankung und Versorgungsstrukturen
34. S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“– update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care
35. Kehlkopfkrebs
36. Frailty and Increased Levels of Symptom Burden Can Predict the Presence of Each Other in HNSCC Patients.
37. Outcome differences in HPV-driven head and neck squamous cell carcinoma attributable to altered human leukocyte antigen frequencies.
38. Is High-Risk Sexual Behavior a Risk Factor for Oropharyngeal Cancer?
39. Should We De-escalate the Treatment for HPV-Positive Tumors?
40. Information architecture for a patient-specific dashboard in head and neck tumor boards
41. Pembrolizumab und Cetuximab als therapeutische Optionen für adenoidzystische Karzinome des Kopf-Hals-Bereiches
42. Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial
43. Effect of postoperative systemic prednisolone on short-term and long-term outcomes in chronic rhinosinusitis with nasal polyps: A multi-centered randomized clinical trial
44. Oral health in patients with different sites of head and neck squamous cell carcinoma is not different.
45. Highlights from the Second International Symposium on HPV infection in head and neck cancer
46. Indication for differential sorting of the rat v-SNARE splice isoforms VAMP-1a and -1b
47. Oral health in HPV-positive and HPV-negative patients with oropharyngeal squamous cell carcinoma
48. Frailty und ihre Bedeutung in der Kopf-Hals-Onkologie
49. Vascular Malformations of the Head and Neck in Children
50. Conversion of hormone and HER-2 receptor in metachronous neck metastases from breast carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.